Navigation Links
In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis

LAWRENCE, Mass., Feb. 17, 2011 /PRNewswire/ -- In celebration of the 31st Annual Dialysis Conference, NxStage(R) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that more than 5,000 patients are using the NxStage System One for home hemodialysis.  The System One is the only portable home hemodialysis machine cleared for home use by the FDA.

"This new milestone demonstrates growing support of home and more frequent hemodialysis with the System One from patients and providers within the renal community," said Jeff Burbank, Founder and CEO of NxStage Medical, Inc. "Many of these patients and providers have become enthusiastic advocates of our therapy and should be credited with growing patient access to the clinical and quality of life benefits possible with more frequent hemodialysis with the System One."

The NxStage® System One™ has been used in approximately four million treatments since its FDA clearance as the first truly portable home hemodialysis system. Unlike traditional dialysis equipment, the System One plugs into a standard electrical outlet and requires no special infrastructure for operation. Trained patients accompanied by their trained partners work the easy-to-use device. Rather than commuting to and from a dialysis clinic three times per week for scheduled treatment sessions lasting three to four hours, NxStage patients have the personal freedom to conduct prescribed treatments at home on their own schedule or to bring the System One with them while traveling. The System One works in concert with NxStage's PureFlow™ SL dialysate preparation system, a compact, easy-to-use system that prepares high-purity dialysate from regular tap water, helping to make daily home hemodialysis even more practical and accessible to patients. The PureFlow SL eliminates the need for bagged dialysate in the home, while still allowing patients to use bagged fluids when they travel.

The 31st Annual Dialysis Conference is being held in Phoenix, AZ from February 20-22nd, with pre-conference symposiums – including a course dedicated to home hemodialysis – on February 19th.  The Annual Dialysis Conference attracts thousands of healthcare practitioners to discuss current developments in dialysis.  NxStage will be celebrating the 5,000 patient milestone at an invitation-only educational event for attendees of the conference on Monday, February 21st.  The event, entitled "Leading a Renal Revolution, Together", will feature a kidney patient sharing his experiences, a leading home hemodialysis nephrologist discussing the need for a paradigm shift in ESRD care, and NxStage's perspective on growth to date in home hemodialysis.

About NxStage MedicalNxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. NxStage is leading the development of the home hemodialysis market in the US with the only portable hemodialysis machine, the System One, cleared for home use by the FDA.  For more information on NxStage and its products, please visit the company's website at

Forward-Looking StatementsThis release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond NxStage's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance or achievements including those factors that may affect future operating results and which are detailed in NxStage's filings with the Securities and Exchange Commission, including Quarterly Report on Form 10Q for the quarter ended September 30, 2010.

In addition, the statements in this press release represent NxStage's expectations and beliefs as of the date of this press release. NxStage anticipates that subsequent events and developments may cause these expectations and beliefs to change. However, while NxStage may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, whether as a result of new information, future events, or otherwise. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.Investor Relations ContactKristen SheppardNxStage Medical, 978-332-5923

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Daiichi Sankyo Co, Ltd. Joins the National Cherry Blossom Festival in Washington D.C. as Centennial Celebration Committee Co-Chair
2. Rev. Nick Hood, III Asks Southeast Michiganders Not to Use Guns During New Years Eve Celebrations
3. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
4. GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits
5. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
6. 6th Annual New York Stem Cell Summit Announces Spinal Cord Injury Panel Participants
7. Zimmer Showcases Newly Acquired Line of Surgical Power Tools at 2011 AAOS Annual Meeting
8. Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19
9. Patient Safety Technologies, Inc. to Present at the ROTH Capital Partners 23rd Annual OC Growth Stock Conference
10. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
11. Innophos Holdings, Inc. Announces Annual Meeting
Post Your Comments:
(Date:12/1/2015)... A federal court has denied the state of ... filed by the Pharmaceutical Care Management Association (PCMA) challenging the ... law that forces employers and consumers to pay drugstores higher ... must now defend a law that raises health care ... Mark Merritt . --> Arkansas ...
(Date:12/1/2015)... 2015 Pharma Tech Outlook recently conducted a ... Data Management Solution Providers - 2015 .  After careful ... CEOs, CIOs, VCs, analysts, and the Pharma Tech Outlook ... top 10 clinical data management solution providers (check out ... and 36 respectively). --> ...
(Date:12/1/2015)... , Dec. 1, 2015  AccuTEC Blades, ... a new corporate logo and brand identity program. ... design and engineering of bladed products where "the ... --> --> Serving manufacturers and ... and auto glass equipment, AccuTEC,s product lines include ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... Integrated Rental Services (“Integrated Rental”), a ... LLC (“JII”). , With support from JII, Integrated Rental is poised for expansion ... centers, clinics, research labs and medical facilities across the United States. , General ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , ... that its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging ... also announced that it has been selected as a 2015 U.S.A. Taste Champion in ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the 1980s we have seen vast improvements in scientific research and discoveries, leading ... strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... that it has been selected as a finalist in this year’s Fierce Innovation ... FierceMobileHealthcare. Next IT Healthcare was recognized as a finalist in the category of ...
Breaking Medicine News(10 mins):